Tenet Healthcare is a medical care facility company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker THC on the NYSE exchange.
Tenet Healthcare stock last closed at $142.68, up 0.49% from the previous day, and has increased 111.79% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.94 percentage points. Tenet Healthcare stock is currently +110.49% from its 52-week low of $67.78, and -16.66% from its 52-week high of $171.20.
As of Nov 29, 2024, there are 95.1M THC shares outstanding. The market capitalization of THC is $13.57B. In the past 24 hours, 490,281 THC shares were traded.
You will need an online brokerage account to access the NYSE market and buy THC stock.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal details so you can invest in THC stock today.
Now that you have filled out your info on the stocks app, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring funds into your new investment account.
After you have figured out the best place to buy Tenet Healthcare stock, it's critical to evaluate their stock before you invest, so you truly understand the risk as well as the opportunity.
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on THC's stock page.
You can use many financial metrics, analyses, models, and charts to gauge THC's true value.
Using relative valuations measures:
You can do additional valuation analysis on THC's stock here.
Out of 11 Equities analysts who give recommendations on THC, the consensus analyst rating on THC is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Ben Hendrix, a top 17% analyst from RBC Capital maintains THC with a buy rating and raises their THC price target from $174.00 to $183.00, on Oct 30, 2024.
David S Macdonald, a top 9% analyst from Truist Securities reiterates THC with a strong buy rating and raises their THC price target from $180.00 to $190.00, on Oct 30, 2024.
A.J. Rice, a top 14% analyst from UBS maintains THC with a strong buy rating and raises their THC price target from $197.00 to $217.00, on Oct 30, 2024.
UBS's A.J. Rice raised their price target on Tenet Healthcare (NYSE: THC) by 10.2% from $197 to $217 on 2024/10/30. The analyst maintained their Strong Buy rating on the stock.
Tenet Healthcare reported its Q3 2024 earnings.
Rice called Q3 "strong across all of its segments, featuring:
The analyst told readers that Tenet Healthcare continues to prioritize investments in its USPI segment, although investments in key hospital growth opportunities also remain a priority, particularly since the company's hospital portfolio is now "more streamlined" after a series of divestitures.
For Q3 2024, Tenet Healthcare reported:
Management guided:
For Q4 2024:
For FY 2024:
Chairman & CEO Saum Sutaria, M.D., commented: "Our businesses continue to produce strong results and generate robust free cash flow with same-store revenue growth and profitability well above our expectations due to the focused execution of our strategy and disciplined operations.
"We have furthered our portfolio transformation and are well-positioned to deliver enhanced value to our patients, physician partners, and shareholders."
Matthew Gillmor, a top 11% analyst from KeyBanc initiates coverage on THC with a strong buy rating and announces their THC price target of $200.00, on Oct 11, 2024.
Jason Cassorla, a bottom 7% analyst from Citigroup maintains THC with a strong buy rating and raises their THC price target from $139.00 to $171.00, on Jul 25, 2024.
You can dig deeper into what analysts are projecting on the Tenet Healthcare stock forecast page.
Last year, THC earnings were $3.13B. In the past three year, THC's earnings have increased by 128.33% per year. This was faster than the Medical Care Facilities industry average of 21.09%.
Last year, THC revenue was $20.98B. Over the last 5 year, THC's revenue has grown by 2.78% per year. This was slower than the Medical Care Facilities industry average of 7.71%.
You can research THC's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at THC have sold more shares than they have bought.
Lisa Y. Foo, EVP Commercial Ops of THC, was the latest THC insider to sell. They sold $530,264.00 worth of THC stock on Oct 31, 2024.
Research more about who owns THC stock here.
No, Tenet Healthcare doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary order types:
Press the Open button and your broker will place the order.
If you want more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in THC, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your THC stock.
To summarize, here are the 6 steps to buy Tenet Healthcare stock:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Tenet Healthcare, create a watchlist today.